ESCAPE Mechanistic Substudies - Ancillary to ESCAPE
NCT00021957 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-18
Summary
To determine the value of serum markers as surrogate endpoints and hemodynamic biomarkers of congestive heart failure.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Heart Failure
- Heart Failure, Congestive
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Robert Califf · Duke University
Eligibility
- Min Age
- 16 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Completion
- 2005-03-31
More Related Trials
-
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
NCT05873634 ·Status: RECRUITING
-
Descriptive Study of Circulating Gene or Protein Inflammatory Biomarkers and Bioimpedance Parameters in a Population of Patients Hospitalized for Decompensated Heart Failure With Preserved or Mildly Reduced Cardiac Function
NCT07320014 ·Status: NOT_YET_RECRUITING
-
Biomarker Guided Discharge of Heart Failure Patients
NCT03103932 ·Status: RECRUITING ·Phase: NA
-
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
NCT06884631 ·Status: RECRUITING
-
DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics
NCT04877652 ·Status: COMPLETED
-
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985 ·Status: RECRUITING
-
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
NCT05747820 ·Status: COMPLETED
-
Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure
NCT00514384 ·Status: COMPLETED
-
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
NCT01685840 ·Status: TERMINATED ·Phase: NA
-
Model for Heart Failure ExAcerbation Reduction Trial
NCT01726985 ·Status: COMPLETED
-
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804 ·Status: COMPLETED
-
Cardiac Power Output in Cardiogenic Shock Patients
NCT05700617 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics
NCT01457053 ·Status: TERMINATED ·Phase: NA
-
Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart Failure
NCT06459999 ·Status: NOT_YET_RECRUITING
-
Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure
NCT06592508 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of a Streamlined Heart Failure Optimization Protocol
NCT05021419 ·Status: COMPLETED ·Phase: NA
-
Heart Failure and a Preserved Ejection Fraction
NCT00586833 ·Status: COMPLETED
-
A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure
NCT03669198 ·Status: COMPLETED ·Phase: NA
-
Community Surveillance of Congestive Heart Failure
NCT00005517 ·Status: COMPLETED
-
SPECT-based Prediction and Evaluation of CRT Efficacy in CHF
NCT03667989 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of EECP in Patients With Heart Failure
NCT03857022 ·Status: UNKNOWN ·Phase: NA
-
Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction
NCT05496439 ·Status: COMPLETED
-
a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure
NCT06587854 ·Status: RECRUITING
-
Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure
NCT04901039 ·Status: TERMINATED
-
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
NCT05479669 ·Status: RECRUITING